Arthur Kuan
Chief Executive Officer · CG Oncology, Inc.
Individual
- 2024
- Apr 16, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Arthur Kuan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Guan-Chyun Liu - $24.81M in CGON purchases and sales in the last 12 months
- James Mulay - $3.78M in CGON purchases and sales in the last 12 months
- Leonard E. Post - $990K in CGON purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Arthur Kuan?
Arthur Kuan is a corporate insider, tracked as Chief Executive Officer of CG Oncology, Inc. (CGON). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Arthur Kuan last file a Form 4?
The most recent primary Form 4 on record is dated 16 April 2026, one of 4 filings going back to 2024.
